期刊文献+

pDsRED-LC3真核表达载体的构建及其在肝癌细胞系HepG2中的表达和定位

Construction of Recombinant pDsRed-LC3 Fusion Protein and Its Expression and Localization in HepG2 Cell
下载PDF
导出
摘要 本实验根据已知的人MAP-LC3序列,以人脑胶质瘤U251细胞cDNA为模板扩增出去除终止密码子的MAP-LC3片段,定向克隆至红色荧光融合蛋白载体pDsRed-N1质粒中,构建了重组质粒pDsRed-LC3.将pDsRed-LC3转染HepG2细胞,48 h后用Western Blot、激光共聚焦显微镜检测融合蛋白在细胞内的表达和分布情况,并观察血清饥饿时细胞发生自噬的情况.结果表明:(1)成功构建pDsRFP-LC3真核表达载体,该载体能在人肝癌细胞中表达;(2)血清饥饿应激实验证明,该载体可以良好地指示自噬泡的形成过程,为研究肿瘤细胞的自噬发生情况提供了一个重要而方便的工具. In this study,according to the nucleotide sequence of MAP-LC3,we successfully constructed the vector that expressed the fusion protein of MAP-LC3 and red fluorescent protein(RFP) in mammalian cells.The recombinant plasmid was identified by restriction endonuclease enzyme analysis and DNA sequence analysis.The plasmid was transfected into HepG2 cells,and the expression and distribution of the MAP-LC3 were observed with Confocal Laser Scanning Microscopy(CLSM) after 48 hours.All of the results indicated that this vector was highly expressed in the HepG2 cells.The red fluorescence was found over the cytoplasm by CLSM.Therefore,we had a conclusion that a recombinant plasmid of MAP-LC3 and RFP was constructed successfully,and it would be an important and convenient tool to study the process of autophagy in HCC.
出处 《南京师大学报(自然科学版)》 CAS CSCD 北大核心 2012年第1期84-88,共5页 Journal of Nanjing Normal University(Natural Science Edition)
基金 国家自然基金(31100964) 江苏省高校科学研究基金(09KJB310002) 江苏大学高级人才科研启动基金(10JDG045)
关键词 红色荧光蛋白 MAP-LC3 自噬 肝癌 red fluorescent protein MAP-LC3 autophagy hepatocarcinoma
  • 相关文献

参考文献21

  • 1Mizushima N,Noda T,Yoshimori T,et al.A protein conjugation system essential for autophagy[J].Nature,1998,395(6700):395-398.
  • 2Levine B,Klionsky D J.Development by self-digestion:molecular mechanisms and biological functions of autophagy[J].Dev Cell,2004,6(4):463-477.
  • 3Moretti L,Yang E S,Kim K W,et al.Autophagy signaling in cancer and its potential as novel target to improve anticancertherapy[J].Drug Resist Updat,2007,10(4/5):135-143.
  • 4Levine B,Kroemer G.Autophagy in the pathogenesis of disease[J].Cell,2008,132(1):27-42.
  • 5Shinohara E T,Maity A.Increasing sensitivity to radiotherapy and chemotherapy by using novel biological agents that alterthe tumor microenvironment[J].Curr Mol Med,2009,9(9):1 034-1 045.
  • 6张志才,邵增务,熊蠡茗,车彪,邓超.LC3Ⅱ在骨肉瘤组织中的表达及自噬上调对其化疗敏感性的影响[J].中国中医骨伤科杂志,2010,18(12):1-2. 被引量:2
  • 7Tanida I,Ueno T,Kominami E.LC3 conjugation system in mammalian autophagy[J].Int J Biochem Cell Biol,2004,36(1):2 503-2 518.
  • 8Rubinsztein D C,Gestwicki J E,Murphy L O,et al.Potential therapeutic applications of autophagy[J].Nature Rev DrugDiscov,2007,6(4):304-312.
  • 9杜海磊,杨卫平,陈聆,施敏敏,陈皓,陈拥军,严佶祺,李勤裕,匡洁,邱伟华.自噬的特异性抑制对肝癌细胞凋亡的调控及其相关机制[J].外科理论与实践,2010,15(6):636-640. 被引量:6
  • 10Maiuri M C,Tasdemir E,Criollo A,et al.Control of autophagy by oncogenes and tumor suppressor genes[J].Cell DeathDiffer,2009,16(1):87-93.

二级参考文献89

  • 1张燕,左国庆,汤为学.奥沙利铂对人肝癌细胞株HepG2体外增殖的影响[J].中华肝脏病杂志,2004,12(6):374-375. 被引量:40
  • 22Ya-ping YANG Zhong-qin LIANG Zhen-lun GU Zheng-hong QIN.Molecular mechanism and regulation of autophagy[J].Acta Pharmacologica Sinica,2005,26(12):1421-1434. 被引量:51
  • 3Ngan CY,Yamamoto H,Takagi A,et al.Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells[J].Cancer Sci,2008,99(1):129-139.
  • 4Benzina S,Altmeyer A,Malek F,et al.High-LET radiation combined with oxaliplatin induce autophagy in U-87 glioblastoma cells[J].Cancer Lett,2008,264(1):63-70.
  • 5Louafi S,Boige V,Ducreux M,et al.Gemeitabine plus oxaliplatin(GEMOX)in patients with advanced hepatocellular carcinoma(HCC):results of a phase Ⅱ study[J].Cancer,2007,109(7):1384-1390.
  • 6Cui Q,Tashiro S,Onodera S,et al.Augmentation of oridonin-induced apoptosis observed with reduced autophagy[J].J Pharmacol Sci,2006,101(3):230-239.
  • 7Caldwell S,Park SH.The epidemiology of hepatocellular cancer:from the perspectives of public health problem to tumor biology[J].J Gastroenterol,2009,44 Suppl 19:96-101.
  • 8Kudo M.Hepatocellular carcinoma 2009 and beyond:from the surveillance to molecular targeted therapy[J].Ontology,2008,75 Suppl 1(1):1-12.
  • 9Lee JG,Choi SB,Kim KS,et al.Central bisectionectomy for centrally located hepatocellular carcinoma[J].Br J Surg,2008,95(8):990-995.
  • 10Zhu AX,Blaszkowsky LS,Ryan DP,et al.Phase Ⅱstudy of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma[J].J Clin Oncol,2006,24(12):1898-1903.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部